LC
LKFT

Lindbrook Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Lindbrook Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.29K Sell
131
-453
-78% -$11.4K ﹤0.01% 2120
2024
Q4 		$16.1K Sell
584
-9
-2% -$251 ﹤0.01% 1413
2024
Q3 		$17.1K Sell
593
-508
-46% -$13.8K ﹤0.01% 1383
2024
Q2 		$27.3K Buy
1,101
+880
+398% +$25K ﹤0.01% 1070
2024
Q1 		$7.12K Sell
221
-8
-3% -$298 ﹤0.01% 1741
2023
Q4 		$9.31K Buy
229
+117
+104% +$4.3K ﹤0.01% 1586
2023
Q3 		$3.87K Sell
112
-5
-4% -$195 ﹤0.01% 1879
2023
Q2 		$4.76K Sell
117
-29
-20% -$1.18K ﹤0.01% 1829
2023
Q1 		$5.64K Buy
146
+13
+10% +$534 ﹤0.01% 1803
2022
Q4 		$5.9K Buy
133
+46
+53% +$1.94K ﹤0.01% 1726
2022
Q3 		$4K Sell
87
-61
-41% -$3.13K ﹤0.01% 1756
2022
Q2 		$8K Sell
148
-134
-48% -$7.95K ﹤0.01% 1347
2022
Q1 		$17K Buy
282
+69
+32% +$4.22K ﹤0.01% 1072
2021
Q4 		$12K Buy
213
+8
+4% +$417 ﹤0.01% 1198
2021
Q3 		$11K Buy
205
+36
+21% +$2.14K ﹤0.01% 955
2021
Q2 		$12K Buy
169
+130
+333% +$9.91K ﹤0.01% 978
2021
Q1 		$3K Sell
39
-53
-58% -$4.88K ﹤0.01% 1416
2020
Q4 		$9K Sell
92
-18
-16% -$2.2K ﹤0.01% 946
2020
Q3 		$16K Buy
110
+32
+41% +$5.33K ﹤0.01% 689
2020
Q2 		$15K Sell
78
-1
-1% -$207 ﹤0.01% 705
2020
Q1 		$15K Buy
79
+3
+4% +$645 0.01% 634
2019
Q4 		$16K Hold
76
– – 0.01% 799
2019
Q3 		$12K Hold
76
– – ﹤0.01% 847
2019
Q2 		$9K Hold
76
– – ﹤0.01% 922
2019
Q1 		$8K Hold
76
– – ﹤0.01% 951
2018
Q4 		$6K Buy
+76
New +$7.71K ﹤0.01% 964

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Lindbrook Capital's LKFT Position: Q1 2025 in Review

Lindbrook Capital reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 78% in Q1 2025, selling an estimated $11.4K and leaving 131 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

Lindbrook Capital first reported a position in LKFT in Q4 2018 and has held it in 26 quarters since. The position peaked at $27.3K in Q2 2024. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • Lindbrook Capital held 131 shares of Lakefront Biotherapeutics American Depositary Shares worth $3.29K as of Q1 2025.
  • Lindbrook Capital sold 453 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $11.4K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2120 holding.
  • Lindbrook Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $27.3K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.